EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS33 - Asthma 4

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry
Impact of asthma as a chronic disease on the quality of life of the patient and his family
Influence of selected cytokines and chemokines on the ventilation efficiency in spirometric examination, in patients with asthma post-COVID-19
Progressive increase of the intervals between omalizumab administration in severe asthma
Proposal of an algorithm for asthma diagnosis using molecular biomarkers
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience
Voice biomarkers: a new tool for asthma management

Chairs

Speakers